Rep. Timmons buys SpaceX stock days after IPO, reigniting ethics debate

A South Carolina Republican bought SpaceX shares within a week of its IPO, ending a six-year trading pause and reviving the Congressional stock-trading debate.

Representative William Timmons purchased stock in Space Exploration Technologies Corp. less than seven days after its Nasdaq debut under ticker SPCX, according to financial disclosures, following a six-year stretch with zero trading activity.

"The timing raises legitimate questions about whether members of Congress have access to information that gives them an edge in public markets," said Kedric Payne, senior director of ethics at the Campaign Legal Center. "When a six-year trading pause ends days after a high-profile IPO, voters deserve an explanation."

The purchase occurred after SpaceX's IPO priced shares at $84 each, valuing Elon Musk's rocket-and-satellite company at roughly $280 billion. Timmons, who serves on the House Financial Services Committee, had not executed a trade since early 2020, according to public records filed under the Stop Trading on Congressional Knowledge Act. The disclosure did not specify the number of shares purchased or the total dollar amount. SPCX shares opened at $92 on their first trading day and have traded above the offer price since, though daily volume has declined 34% from the opening session peak.

The transaction threatens to reignite a bipartisan push to ban members of Congress from trading individual stocks — legislation that has stalled despite polling showing 76% of voters support a prohibition. A formal complaint to the Office of Congressional Ethics or an SEC inquiry could follow, creating reputational risk for SpaceX and potential volatility for SPCX shares during their critical early trading weeks.

The STOCK Act, signed into law in 2012, requires lawmakers to disclose trades exceeding $1,000 within 45 days. Violations carry fines but have rarely resulted in prosecution. A 2023 investigation by Insider found that 97 members of Congress or their families had traded stocks in companies that could be affected by their committee work since 2019. The last time a similar controversy triggered a formal ethics review — following Senator Burr's 2020 stock sales before the Covid-19 market crash — the S&P 500 fell 12% in the subsequent month as investor confidence in regulatory oversight weakened.

Timmons's purchase comes as SpaceX transitions from a closely held private company to a publicly traded entity. The IPO was one of the most anticipated listings of the decade, drawing demand from institutional investors and retail traders alike. The company's prospectus highlighted its dependence on government contracts — including NASA's Artemis program and the Department of Defense's Starshield project — as key revenue drivers, areas where the House Financial Services Committee and the broader Appropriations process exercise direct oversight.

A Pattern of Political Risk

The episode adds to a growing list of Congressional trading controversies that have eroded public trust. Senator Richard Burr's stock sales before the 2020 Covid-19 crash — which triggered an FBI investigation — and former Speaker Nancy Pelosi's options trades in Big Tech companies have kept the issue in the spotlight. The proposed Ban Congressional Stock Trading Act, reintroduced in 2025, would require lawmakers to place assets in blind trusts or index funds, but has not advanced past committee in either chamber. A 2024 analysis by the Congressional Research Service estimated that roughly 200 lawmakers currently hold individual equities, representing an aggregate portfolio of at least $500 million.

For SpaceX, the association with a Congressional ethics question at the start of its public-market life introduces a narrative risk that few IPOs face. The stock's performance in the first 30 trading days — a period that often sets institutional positioning for quarters ahead — could be affected if the controversy escalates into a formal investigation.

What Comes Next

The House Ethics Committee could open a preliminary inquiry if a complaint is filed. Separately, the SEC may review whether Timmons had access to non-public information about the IPO timeline or valuation through his committee role. No formal investigation has been announced. The broader market impact may be felt in renewed legislative momentum: a ban on Congressional stock trading would shift billions of dollars in assets into passive funds, potentially reducing single-stock volatility in names with high lawmaker ownership.

This article is for informational purposes only and does not constitute investment advice.